A Network-Based Mixed Methods Approach to Analyze Current Perspectives on Personalized Oncological Medicine in Austria
Open Access
- 12 December 2020
- journal article
- research article
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 10 (4) , 276
Abstract
Personalized medicine (PM) to tailor healthcare (HC) to the individual, is a promising but challenging concept. So far, no study exists investigating stakeholders’ perspectives on PM in oncology in Austria potentially hindering implementation, which was the aim of this study. We performed semi-structured interviews among experts (n = 14) and cancer patients (n = 2) of the Vienna General Hospital and the Medical University of Vienna and analyzed them by a mixed methods network theoretical approach. Study results show a great variety of topics addressed by the interviewees. Clear differences in the topic selection between patients and experts could be observed. Patient-doctor relationship was the most prominent theme among experts, whereas HC systems and public health in PM was more relevant for the patients. Although promising new molecular pathology methods were explicitly mentioned, the experts believed that their practical implementation and the implementation of PM in standard care will take a long time in Austria. A variety of concerns regarding PM were mentioned by the experts, including communication issues and knowledge gaps. Besides important insights into the current situation of PM in Austria, the study has shown that network theory is a powerful tool for analyzing qualitative interview data.Keywords
This publication has 34 references indexed in Scilit:
- Re-focusing the ethical discourse on personalized medicine: a qualitative interview study with stakeholders in the German healthcare systemBMC Medical Ethics, 2013
- Content analysis and thematic analysis: Implications for conducting a qualitative descriptive studyNursing & Health Sciences, 2013
- Mixed Methods in Biomedical and Health Services ResearchCirculation: Cardiovascular Quality and Outcomes, 2013
- Personalized oncology: Recent advances and future challengesMetabolism, 2013
- Challenges in the Development and Reimbursement of Personalized Medicine—Payer and Manufacturer Perspectives and Implications for Health Economics and Outcomes Research: A Report of the ISPOR Personalized Medicine Special Interest GroupValue in Health, 2012
- Attitudes of Patients With Cancer About Personalized Medicine and Somatic Genetic TestingJournal of Oncology Practice, 2012
- What German experts expect from individualized medicine: problems of uncertainty and future complication in physician–patient interactionClinical Ethics, 2012
- Personalized medicine in oncology: the future is nowNature Reviews Drug Discovery, 2010
- Enumeration aspects of maximal cliques and bicliquesDiscrete Applied Mathematics, 2009
- Network Analysis in the Social SciencesScience, 2009